| 15.08. | Las acciones europeas suben impulsadas por sectores defensivos tras débiles datos de Ch.. |  |
| 15.08. | Point marchés-Les actions freinées par la nervosité sur la Chine, le pétrole baisse |  |
| 15.08. | Wall Street attendue dans le rouge, la Chine inquiète | |
| 15.08. | Point marchés-Wall Street attendue dans le rouge, la Chine inquiète | |
| 15.08. | Nikkei 225 Up 1.1% on Wall Street Cues, Earnings Season |  |
| 15.08. | AstraZeneca, Daiichi Sankyo Say Their Breast Cancer Drug Delayed Disease Progression in.. | |
| 15.08. | FTSE 100 inches higher as AstraZeneca counters China worries | |
| 15.08. | Las bolsas europeas suben, mientras los débiles datos de China avivan la preocupación | |
| 15.08. | European shares edge higher; weak China data stokes worries | |
| 15.08. | ASTRAZENECA : des résultats positifs dans le cancer du sein | |
| 15.08. | Japan Index Rallies on Upbeat Economic Reports; Daiichi Sankyo Soars 14% on Legal Victo.. | |
| 15.08. | AstraZeneca-Daiichi's breast cancer drug improves survival in study | |
| 15.08. | Enhertu Significantly Delayed Breast Cancer Progression in Trial, AstraZeneca Says | |
| 15.08. | AstraZeneca's Enhertu Prolongs Progression-free Survival in Late-stage Breast Cancer St.. | |
| 15.08. | Daiichi Sankyo Shares Gain After It Wins Dispute Over Cancer Drug Technology | |
| 12.08. | Seagen Loses Arbitration Against Daiichi Sankyo; Sees No Impact on Existing Business | |
| 12.08. | Seagen loses arbitration against Daiichi Sankyo over drug technology | |
| 12.08. | Seagen loses arbitration ruling against Daiichi Sankyo | |
| 12.08. | Guardant Health Says FDA Approved Liquid Biopsy Test as Companion Diagnostic for Lung C.. | |
| 12.08. | ASTRAZENECA : la FDA étend son approbation d'Enhertu | |
| 12.08. | AstraZeneca, Daiichi Sankyo Receive FDA Approval for Lung Cancer Drug | |
| 12.08. | AstraZeneca's Lung Cancer Drug Secures US FDA's Nod | |
| 12.08. | AstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer Treatment | |
| 10.08. | Japan's Nikkei falls as chip shares track U.S. peers lower | |
| 09.08. | ASTRAZENECA : résultats prometteurs dans le cancer du poumon | |
| 09.08. | AstraZeneca Reports Promising Data From Lung Cancer Trial | |
| 09.08. | AstraZeneca JV's Non-small Cell Lung Cancer Drug Show Favorable Results On Trial | |
| 08.08. | ASTRAZENECA : l'approbation d'Enhertu étendue aux Etats-Unis | |
| 08.08. | AstraZeneca's Enhertu Breast Cancer Treatment Approved for Use in US | |
| 08.08. | AstraZeneca's Breast Cancer Drug Wins US FDA's First-in-class Approval | |
| 05.08. | Enhertu, de AstraZeneca, obtiene una esperada autorización para el cáncer de mama en EE.. | |
| 05.08. | AstraZeneca's Enhertu wins keenly-anticipated U.S. breast cancer nod | |
| 04.08. | Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March.. | |
| 04.08. | Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023 | |
| 01.08. | Daiichi Sankyo's Fiscal Q1 Attributable Profit Declines 47% on Higher Expenses | |
| 27.07. | Daiichi Sankyo Concludes Restricted Share-based Compensation | |
| 26.07. | MODA : Leonard Paris entra nell'orbita di Sankyo Seiko (MFF) |  |
| 25.07. | ASTRAZENECA : a obtenu un examen prioritaire aux États-Unis | |
| 25.07. | Sankyo Seiko to purchase French luxury fashion house Leonard | |
| 25.07. | AstraZeneca, Daiichi Sankyo's Enhertu Awarded Priority Review in the US to Treat Breast.. | |
| 25.07. | AstraZeneca's Enhertu Treatment Granted Priority Review Status by FDA | |
| 21.07. | SANKYO : Notice concerning Determination of Certain Details of the Issuance of Stock Compe.. | |
| 19.07. | European Commission Approves AstraZeneca, Daiichi Sankyo's Enhertu for Use in EU | |
| 19.07. | Nikkei 225 Up 0.7% on Federal Reserve Outlook | |
| 19.07. | ASTRAZENECA : indication élargie pour Enhertu dans l'UE | |
| 19.07. | AstraZeneca Says Metastatic Breast Cancer Treatment Enhertu Approved in EU | |
| 11.07. | Nikkei 225 Up 1.1% on Election Win By Ruling Bloc, Softer Yen | |
| 06.07. | Sankyo to Grant Stock Compensation-type Options | |
| 05.07. | SANKYO : Notice concerning Issuance of Stock Compensation-type Stock Options (Subscription.. | |
| 27.06. | AstraZeneca Partner Daiichi Sankyo Says EMA's Committee Backs Approval of Trastuzumab D.. | |
| 27.06. | ASTRAZENECA : avis favorable du CHMP pour Enhertu | |
| 27.06. | AstraZeneca's Lynparza, Enhertu Win EU Panel's Backing for Approval in Breast Cancer | |
| 27.06. | AstraZeneca-Daiichi Sankyo Enhertu Breast Cancer Drug Is Recommended for EU Approval | |
| 22.06. | European Medicines Agency Validates AstraZeneca-Daiichi Sankyo Application for Breast C.. | |
| 22.06. | ASTRAZENECA : l'EMA accepte un dossier dans le cancer du sein | |
| 22.06. | AstraZeneca Partner Daiichi Sankyo Says Type II Variation Application for Breast Cancer.. | |
| 14.06. | Nikkei 225 Down 1.3% on Central Bank Outlooks, Wall Street Cues | |
| 07.06. | Japan's Nikkei hits over 2-month high on automakers boost | |
| 06.06. | MARCHÉS : regain de confiance après la levée de restrictions anti-Covid en Chine | |
| 06.06. | Tokyo a profité du yen faible, Hong Kong salue la levée des restrictions à Pékin | |
| 06.06. | AstraZeneca's Enhertu Delays Breast Cancer Progression, Death in Late-stage Study | |
| 06.06. | Tokyo en repli après le rapport sur l'emploi américain | |
| 01.06. | Nikkei 225 Up 0.7% As Softer Yen Boost Export Issues | |
| 01.06. | Japanese shares rise as automakers rally after report forecasts positive earnings | |
| 01.06. | Japanese shares rise led by automakers | |
| 25.05. | Nikkei 225 Slips 0.3% on Stronger Yen | |
| 25.05. | Japanese shares end lower on Wall Street weakness | |
| 12.05. | Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March.. | |
| 12.05. | Sankyo Co., Ltd. Announces Dividend for the Year Ended March 31, 2022, Payable on June .. | |
| 12.05. | Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023 | |
| 05.05. | AstraZeneca, Daiichi Sankyo Say US FDA Clears Enhertu to Treat Breast Cancer; AstraZene.. | |
| 05.05. | AstraZeneca, Daiichi's Breast Cancer Treatment Wins US Approval | |
| 05.05. | AstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer Treatment | |
| 04.05. | Sankyo Acquires Own Shares for Nearly $6 Million in April | |
| 02.05. | SANKYO : Notice concerning Status and Completion of Repurchase of the Company's Own Shares | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
